Atlas Trials

Efficacy and Tolerability of the Combination of Valproic Acid and Lenalidomide in the Treatment of Patients With Myelodysplastic Syndrome

Clinical trial NCT00977132 · TERMINATED

Trial details

NCT number
NCT00977132
Sponsor
Heinrich-Heine University, Duesseldorf
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome MDS
Start date
2009-10-01
Primary completion
2013-05-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.